Business

Stocks to Watch: Adani Enterprises, TCS, Bandhan Bank, Lodha Developers and more


Image count1 / 12

Adani Enterprises | The company said its subsidiary Adani Defence Systems & Technologies, along with Prime Aero Services LLP, will acquire a 72.8% stake in Flight Simulation Technique Centre (FSTC) for ₹820 crore. The deal, signed on November 27, makes ADSTL a major stakeholder in India’s largest independent flight training and simulation provider.

tcs shares
Image count2 / 12

TCS | The IT company announced a five-year deal with SAP to drive enterprise-wide Cloud and Generative AI transformation. Under the partnership, TCS will streamline SAP’s IT landscape, enable smoother operations, and strengthen AI-led capabilities—aiming for faster development cycles, lower costs, and better alignment between IT and business goals.

Bajaj Healthcare share price
Image count3 / 12

Bajaj Healthcare | The company has appointed industry veteran Shreekumar Shankarnarayan Nair as its Chief Operating Officer, effective immediately. Approved via a board circular on November 27, his appointment brings over 40 years of pharma leadership experience, including senior roles at Alembic and Glenmark.

Bandhan Bank share price
Image count4 / 12

Bandhan Bank | The company has approved the sale of its NPA and written-off loan portfolios worth over ₹6,900 crore through a bidding and auction process involving ARCs. The move aims to clean up the balance sheet, with Swiss Challenge bidding for NPAs and auction for written-off assets.

wipro share price
Image count5 / 12

Wipro | The company announced a multi-year deal with Odido Netherlands B.V. to modernise its IT landscape and enhance customer experience across enterprise and consumer segments. The partnership will use AI-led solutions to boost engagement, productivity and operational efficiency. It also adopts a self-funded model, where productivity savings are reinvested to support ongoing digital innovation.

Ashoka Buildcon, Maharashtra traffic management, Nagpur, Mumbai, Pune, Marathwada, Konkan, Intelligent Traffic System, infrastructure development, road safety, ashoka buildcon share price, ashoka buildcon stock, ashoka buildcon shares,
Image count6 / 12

Ashoka Buildcon | The company has been temporarily barred from NHAI bids for one month, or until an Expert Committee investigation concludes, following the fall of two precast girders on NH-66 that killed a driver. The company denies endangering public safety.

Macrotech Developers share price, Macrotech Developers stock, Macrotech Developers shares, Macrotech Developers India Ratings and Research, India Ratings and Research upgrades macrotech ratings, macrotech rating, macrotech developers credit rating,
Image count7 / 12

Lodha Developers Ltd | Formerly Macrotech Developers, said the Supreme Court has allowed the restitution of ₹520.80 crore it had deposited as security in the V Hotels case. The amount, along with accrued interest, will be refunded, reaffirming Lodha as the bona fide successful Resolution Applicant with rightful interest in the property.

Image count8 / 12

Global Health Ltd | The operator of Medanta hospitals, has expanded its NCR presence with a new 550-bed super speciality hospital in Noida. Inaugurated by UP Chief Minister Yogi Adityanath, the Sector 50 facility will offer advanced tertiary and quaternary care across 25+ super specialities and serve patients across Delhi-NCR and western Uttar Pradesh.

tata technologies share price
Image count9 / 12

Tata Technologies | The company has completed its €75 million acquisition of Germany’s Es-Tec Group ahead of schedule, strengthening its position as a global engineering and R&D partner for top automakers.

emcure pharma
Image count10 / 12

Emcure Pharmaceuticals | The company said the Maharashtra GST Department conducted a search and seizure operation at its Mumbai offices from November 24 to 26. The inspection was led by the Assistant Commissioner of State Tax, the company informed in a stock exchange filing.

zydus lifesciences, share price, stock price, bse ,nse, corporate announcements, pharma stocks
Image count11 / 12

Zydus Lifesciences | The company has received tentative USFDA approval for empagliflozin and linagliptin tablets (10 mg/5 mg and 25 mg/5 mg), the generic equivalents of Glyxambi. The combination is used to improve glycaemic control in adults with type 2 diabetes. The tablets will be manufactured at the company’s SEZ facility in Ahmedabad.

RVNL Share price
Image count12 / 12

RVNL | The company has received a Letter of Acceptance (LoA) from East Coast Railway for a project valued at ₹9.6 crore.



Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top